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Abstract
Background: Elevated alanine aminotransferase (ALT) levels may be associated with metabolic syndrome and
cardiovascular diseases. This study aimed to investigate the association between elevated ALT levels and
cardiometabolic risk factors in a rural Chinese population.
Methods: This was a cross-sectional study conducted from July 2012 to August 2013, including 11,573 subjects (5,357
men and 6,216 women) aged ≥35 years in rural areas of Liaoning Province. A physical examination was performed
and metabolic indicators were examined under standard protocols. Subjects were divided into those with elevated ALT
levels (>40U/L) and those with normal ALT levels (≤40U/L).
Results: Participants with elevated ALT levels had higher levels of almost all cardiometabolic risk factors than those
with normal ALT levels. In individuals with elevated ALT levels, weight, height, waist circumference, and body mass
index (BMI), which are indicators for general and abdominal obesity, were significantly higher (p < 0.001) than those in
individuals with normal ALT levels. There was no significant difference in race, current smoking, or physical activity
between the two groups. Other cardiometabolic risk factors, such as systolic blood pressure, diastolic blood pressure,
and fasting plasma glucose, TC, TG, low-density lipoprotein cholesterol, and serum uric acid levels, were higher in
participants with elevated ALT levels than in those with normal ALT levels. Logistic regression analysis showed that
male sex, younger age, and the presence of high TC, high TG, and low high-density lipoprotein cholesterol levels,
current smoking status, BMI ≥25 kg/m2, abdominal obesity, hyperuricemia, and HtgW phenotype were significantly
(p < 0.05) associated with elevated ALT levels. Sex-related differences were also investigated. For men, hypertension
(OR 1.33, 95 % CI 1.08–1.62), high TC levels (OR 1.63, 95 % CI 1.23–2.17), high TG levels (OR 1.62, 95 % CI 1.25–2.09),
BMI ≥25 kg/m2 (OR 1.52, 95 % CI 1.07–2.18), and hyperuricemia (OR 1.92, 95 % CI 1.52–2.40) were significantly (p < 0.05)
related to elevated serum ALT levels, but this was not observed in women.
Conclusions: There are significant relationships of elevated ALT levels with cardiometabolic risk factors and several
sex-related differences in rural Chinese. Elevated serum ALT levels are associated with a worse cardiac risk profile.
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Background
Alanine aminotransferase (ALT) is considered as a sensi-
tive indicator of liver cell injury [1, 2]. Because ALT is
closely related to fat accumulation in the liver [3], it is
also commonly considered as a surrogate marker for
nonalcoholic fatty liver disease (NAFLD) in some epi-
demiological studies [4, 5]. Recent findings have shown
that nonalcoholic fatty liver disease is strongly associated
with obesity, metabolic syndrome, and diabetes mellitus,
as well as cardiovascular events [6–9]. Several studies
have indicated that elevated serum ALT levels are associ-
ated with age, sex, obesity, waist circumference, fasting
blood glucose levels, and serum triglyceride levels [10,
11]. Therefore, patients with cardiometabolic risk factors
usually have elevated serum ALT activity, and serum
ALT levels are commonly used to monitor liver function
in people with metabolic disorders. However, there are
limited data linking elevated serum ALT levels and phys-
ical activity [12]. The HtgW phenotype is represented by
the simultaneous presence of elevated serum triglyceride
levels and an increased waist circumference [13], and
this phenotyope is a major determinant of cardiometa-
bolic risk among Turks [14].
Several large-scale, population-based surveys have eval-
uated serum ALT levels in developed countries, but there
are limited data from developing countries. In China, pre-
vious studies on ALT and cardiometabolic risk factors had
limitations in the study design and a small sample size.
Large-scale, population-based, cross-sectional surveys ad-
dressing the associations between elevated serum alanine
aminotransferase levels and cardiometabolic risk factors in
a rural Chinese population have not been performed.
Therefore, we conducted this study to investigate 1) the
association between elevated ALT levels and cardiometa-
bolic risk factors in a rural Chinese population and 2) dif-
ferences in cardiometabolic characteristics associated with
elevated ALT levels in both sexes.
Methods
Study population
Liaoning Province is located in Northeast China. From
July 2012 to August 2013, a representative sample aged
≥35 years was selected to describe the prevalence, inci-
dence and natural history of cardiovascular risk factors
in rural areas of Liaoning Province, which is called
Northeast China Rural Cardiovascular Health Study
(NCRCHS). The study adopted a multi-stage, stratified
randomly cluster-sampling scheme. In the first stage, 3
counties (Dawa, Zhangwu, and Liaoyang County) were
selected from the eastern, southern, and northern region
of Liaoning province. In the second stage, one town was
randomly selected from each county (a total of 3 towns).
In the third stage, 8–10 rural villages from each town
were randomly selected (a total of 26 rural villages). All
the eligible permanent residents aged ≥ 35 years from
each village were invited to attend the study (a total of
14,016 participants). Of those, 11,956 participants agreed
and completed the present study and the response rate
was 85.3 %. The study was approved by the Ethics Com-
mittee of China Medical University (Shenyang, China).
All procedures were performed in accordance with the
ethical standards. Written consent was obtained in all
participants after they had been informed of the objec-
tives, benefits, medical items and confidentiality agree-
ment of personal information. If the participants were
illiterate, we obtained the written informed consents
from their proxies. In this report, we used data of base-
line and only participants with a complete set of data re-
garding the variables analyzed in the study were
included, making a final sample size of 11,573 (5,357
men and 6,216 women).
Data collection and measurements
Data was collected during a single clinic visit by cardiol-
ogists and trained nurses using a standard questionnaire
by face-to-face interview. Before the survey was per-
formed, we invited all eligible investigators to attend the
organized training. The training contents included the
purpose of this study, how to administer the question-
naire, the standard method of measurement, the import-
ance of standardization, and the study procedures. A
strict test was evaluated after this training, only those
who scored perfectly on the test could become investiga-
tors. During data collection, our inspectors had further
instructions and support.
Data on demographic characteristics, lifestyle risk fac-
tors, family income, medical history, were obtained by
interview with a standardized questionnaire. There was
a central steering committee with a subcommittee for
quality control. Educational level was divided into pri-
mary school or below, middle school and high school or
above. Family income was classified as ≤5000, 5000–
20000 and >20000 CNY/year.
According to American Heart Association protocol, blood
pressure was measured three times at 2-min intervals after
at least 5 min of rest using a standardized automatic elec-
tronic sphygmomanometer (HEM-741C; Omron, Tokyo,
Japan). The calibration of the Omron device was checked
using a standard mercury sphygmomanometer every month
by two doctors according to the British Hypertension
Society protocol [15]. The participants were advised to
avoid caffeinated beverages and exercise for at least
30 min before the measurement. During the measure-
ment, the participants were seated with the arm supported
at the level of the heart. The mean of three BP measures
was calculated and used in all analyses.
Weight and height were measured to the nearest
0.5 kg and 0.1 cm respectively with the participants in
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light weight clothing and without shoes. WC was mea-
sured at the midpoint between the lower rib and upper
margin of the iliac crest using a non-elastic tape (to the
nearest 0.1 cm), with the participants standing at the
end of normal expiration. The body mass index (BMI)
was calculated as weight in kilograms divided by the
square of the height in meters.
Fasting blood samples were collected in the morning
after at least 12 h of fasting for all participants. Blood
samples were obtained from an Antecubital vein into
Vacutainer tubes containing EDTA. Serum was subse-
quently isolated from the whole blood, and all serum
samples were frozen at −20 °C for testing at a central,
certified laboratory. Fasting plasma glucose (FPG), total
cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C),
triglyceride (TG), Serum uric acid(SUA) and other rou-
tine blood biochemical indexes were analyzed enzymati-
cally on an Olympus AU640 autoanalyzer (Olym-pus,
Kobe, Japan). All laboratory equipment was calibrated
and blinded duplicate samples were used.
Definitions
According to JNC-7 report [16], hypertension was de-
fined as SBP ≥140 mm Hg and/or DBP ≥90 mm Hg
and/or use of antihypertensive medications. Diabetes
mellitus was diagnosed according to the WHO criteria
[17]: FPG ≥7 mmol/L (126 mg/dL) and/or being on
treatment for diabetes. High TC was defined as TC
≥6.21 mmol/L (240 mg/dL). High TG was defined as TG
≥2.26 mmol/L (200 mg/dL). High LDL-C was de fined
as LDL-C ≥4.16 mmol/L (160 mg/dL). Low HDL-C was
defined as HDL-C <1.03 mmol/L (40 mg/dL) [18]. Hy-
peruricemia was defined as serum uric acid ≥416 μmol/l
in men and ≥357 μmol/l in women according to guide-
lines [19]. BMI was categorized into 3 groups as normal
(BMI <25 kg/m2), overweight (25 ≤ BMI <30 kg/m2) and
obesity (BMI ≥30 kg/m2), according to the World Health
Organization (WHO) criteria [20]. Abdominal obesity
was defined as WC ≥88 cm for females and WC
≥102 cm for males [21]. HtgW phenotype was defined
as fasting triglycerides ≥1.7 mM combined with abdom-
inal obesity. Elevated serum ALT level was defined as
ALT >40 U/L [22].
The smoking and alcohol consumption status were
also surveyed. Self-reported smoking and drinking were
obtained from the questionnaire. Current smokers or
drinkers were defined as people who were currently
smoking or drinking. Former and never smokers or
drinkers were treated as the other category.
Physical activity included occupational and leisure-
time physical activity. A detailed description of the
methods for assessing physical activity has been pre-
sented elsewhere. Occupational and leisure-time physical
activity were merged and regrouped into the following
three categories: 1) low—subjects who reported light
levels of both occupational and leisure-time physical ac-
tivity, 2) moderate—subjects who reported moderate or
high levels of either occupational or leisure-time physical
activity and 3) high—subjects who reported a moderate
or high level of both occupational and leisure-time phys-
ical activity [23].
Statistical analysis
Descriptive statistics were calculated for all the variables,
including continuous variables which were normally dis-
tributed (reported as mean values and standard devia-
tions) and categorical variables (reported as numbers
and percentages). Differences among ALT and sex cat-
egories were evaluated using Student’s t-test, or the χ2-
test as appropriate. Multivariate logistic regression ana-
lyses were used to identify the association between ele-
vated ALT and caridometabolic risk factors with odds
ratios (ORs) and corresponding 95 % confidence inter-
vals (CIs) calculated. All the statistical analyses were per-
formed using SPSS version 17.0 software (SPSS Inc,
Chicago, Illinois, USA), and P values less than 0.05 were
considered to be statistically significant.
Results
Baseline characteristics of the study population
Table 1 shows baseline data according to serum ALT
levels and sex. A total of 11,573 subjects (5,357 men and
6,216 women) participated in the study. The general
characteristics of the study population with and without
elevated serum ALT levels are shown in Table 1. The
overall prevalence of elevated ALT levels (≥40U/L) was
7.4 % (n = 860). Subjects with elevated serum ALT levels
were more likely to be men (men, 10.5 % vs women,
4.8 %, p < 0.001), and had a higher percentage of current
drinking compared with those with normal serum ALT
levels. Additionally, subjects with elevated ALT levels
had higher levels of SBP, DBP, and FPG, TC, TG, LDL-C,
and serum uric acid levels, but lower HDL-C levels than
those with normal ALT levels. Furthermore, subjects
with elevated ALT levels had a heavier weight, taller
height, greater waist circumference, and higher BMI
compared with those with normal serum ALT levels.
Adjusted Odd ratios of associated cardiometabolic risk
factors for elevated serum ALT levels
Table 2 shows the adjusted ORs for the associations be-
tween elevated serum ALT levels and certain cardio-
metabolic risk factors. Subjects with elevated serum
ALT levels had higher levels of almost all cardiometa-
bolic risk factors than those with normal serum ALT
levels. Participants who had elevated serum ALT levels
showed a more pronounced prevalence of hypertension
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Table 1 Characteristics of participants according to the serum levels of ALT
Variables Total ALT≤ 40 ALT > 40 P value Male Female P value
(n = 11573) (n = 10713) (n = 860) (n = 5357) (n = 6216)
Age (year) <0.001 <0.001
35–44(%) 2751(23.8) 2487(23.2) 264(30.7) 1218(22.7) 1533(24.7)
45–54(%) 3598(31.1) 3292(30.7) 306(35.6) 1621(30.3) 1977(31.8)
55–64(%) 3481(30.0) 3257(30.4) 224(26.0) 1634(30.5) 1847(29.7)
≥65(%) 1743(15.1) 1677(15.7) 66(7.7) 884(16.5) 859(13.8)
Sex <0.001
male(%) 5357(46.3) 4794(44.7) 563(65.5)
female(%) 6216(53.7) 5919(55.3) 297(34.5)
Race 0.431 0.645
Han(%) 10968(94.8) 10148(94.7) 820(95.3) 5071(94.7) 5897(94.9)
Others(%) 605(5.2) 565(5.3) 40(4.7) 286(5.3) 319(5.1)
Current smoking status (%) 4086(35.3) 3757(35.1) 329(38.3) 0.060 3056(57.0) 1030(16.6) <0.001
Current drinking status (%) 2617(22.6) 2333(21.8) 284(33.0) <0.001 2434(45.4) 183(2.9) <0.001
Education (%) <0.001 <0.001
Primary school or below 5763(49.8) 5391(50.3) 372(43.3) 2232(41.7) 3531(56.8)
Middle school 4717(40.8) 4325(40.4) 392(45.6) 2512(46.9) 2205(35.5)
High school or above 1093(9.4) 997(9.3) 96(11.2) 613(11.4) 480(7.7)
Physical activity (%) 0.886 <0.001
Low 3441(29.7) 3192(29.8) 249(29.0) 1209(22.6) 2232(35.9)
Moderate 7479(64.6) 6912(64.5) 567(65.9) 3851(71.9) 3628(58.4)
High 653(5.7) 609(5.7) 44(5.1) 297(5.5) 356(5.7)
Family income (CNY/year, %) <0.001 <0.001
≤5000 1441(12.5) 1367(12.8) 74(8.6) 720(13.4) 721(11.6)
5000–20000 6306(54.5) 5864(54.7) 442(51.4) 2870(53.6) 3436(55.3)
>20000 3826(33.0) 3482(32.5) 344(40.0) 1767(33.0) 2059(33.1)
Diabetes 1199(10.4) 1074(10.0) 125(14.5) <0.001 529(9.9) 670(10.8) 0.119
Hypertension 5914(51.1) 5409(50.5) 505(58.7) <0.001 2889(53.9) 3025(48.7) <0.001
Weight(kg) 64.1 ± 11.4 63.5 ± 11.0 71.5 ± 13.3 <0.001 68.6 ± 11.1 60.3 ± 10.1 <0.001
Height(cm) 160.6 ± 8.2 160.4 ± 8.2 163.5 ± 8.3 <0.001 166.4 ± 6.3 155.6 ± 6.1 <0.001
BMI(Kg/m2) 24.8 ± 3.7 24.7 ± 3.6 26.7 ± 4.2 <0.001 24.7 ± 3.5 24.9 ± 3.8 <0.001
WC(cm) 82.4 ± 9.8 82.0 ± 9.7 88.0 ± 10.1 <0.001 83.8 ± 9.8 81.3 ± 9.7 <0.001
SBP (mmHg) 141.8 ± 23.5 141.5 ± 23.5 144.8 ± 22.1 <0.001 143.7 ± 22.6 140.1 ± 24.0 <0.001
DBP(mmHg) 82.1 ± 11.8 81.7 ± 11.7 85.9 ± 12.0 <0.001 83.8 ± 11.8 80.6 ± 11.5 <0.001
FPG (mmol/L) 5.9 ± 1.6 5.9 ± 1.6 6.1 ± 1.6 <0.001 6.0 ± 1.7 5.9 ± 1.6 0.004
TC (mmol/L) 5.2 ± 1.1 5.2 ± 1.1 5.5 ± 1.3 <0.001 5.2 ± 1.0 5.3 ± 1.1 <0.001
TG (mmol/L) 1.6 ± 1.5 1.6 ± 1.4 2.3 ± 2.1 <0.001 1.7 ± 1.6 1.6 ± 1.3 0.145
LDL-C (mmol/L) 2.9 ± 0.8 2.9 ± 0.8 3.1 ± 0.9 <0.001 2.9 ± 0.8 3.0 ± 0.8 <0.001
HDL-C (mmol/L) 1.4 ± 0.4 1.4 ± 0.4 1.3 ± 0.4 <0.001 1.4 ± 0.4 1.4 ± 0.3 0.645
Serum uric acid (mg/dL) 291.9 ± 84.9 288.1 ± 82.6 338.9 ± 97.8 <0.001 333.7 ± 83.5 255.8 ± 67.8 <0.001
Data are expressed as the mean ± SD or as n (%)
Abbreviations: CNY China Yuan (1CNY = 0.161 USD); SBP systolic blood pressure; DBP diastolic blood pressure; BMI body mass index; WC waist circumference;
TC total cholesterol; TG triglyceride; LDL-C low-density lipoprotein cholesterol; HDL-C high-density lipoprotein cholesterol; FPG fasting plasma glucose
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(adjusted OR, 1.30; 95 % CI, 1.11–1.53), hypercholes-
terolemia (adjusted OR, 1.57; 95 % CI, 1.26–1.96),
hypertriglyceridemia (adjusted OR, 1.59; 95 % CI, 1.28–
1.96), low HDL-C levels (adjusted OR, 1.27; 95 % CI,
1.03–1.55), BMI ≥25 kg/m2 (adjusted OR, 1.51; 95 %
CI, 1.18–1.94), abdominal obesity (adjusted OR, 1.53;
95 % CI, 1.19–1.96), hyperuricemia (adjusted OR, 1.78;
95 % CI, 1.47–2.16), and HtgW phenotype (adjusted
OR, 1.37; 95 % CI, 1.07–1.76) compared with those
with normal serum ALT levels, after adjusting for sex,
age, race, BMI, current smoking status, current drink-
ing status, hypertension, diabetes, education, physical
activity, and income.
Association between elevated ALT levels and
cardiometabolic risk factors according to sex
Subsequent to adjustment for confounding factors, the
data showed dramatically different results in multiple logis-
tic regression according to sex (Table 3). For men, cardio-
metabolic risk factors that were associated with elevated
ALT levels included age (OR,0.95; 95 % CI, 0.94–0.96),
current smoking status (OR,0.62; 95 % CI, 0.52–0.75),
hypertension (adjusted OR, 1.33; 95 % CI, 1.08–1.62),
hypercholesterolemia (adjusted OR, 1.63; 95 % CI, 1.23–
2.17), hypertriglyceridemia (adjusted OR, 1.62; 95 % CI,
1.25–2.09), BMI ≥25 kg/m2 (adjusted OR, 1.52; 95 % CI,
1.07–2.18), and hyperuricemia (adjusted OR, 1.92; 95 %
CI, 1.54–2.40). However, for women, cardiometabolic
risk factors that were significantly related to elevated
ALT levels included age (OR, 0.98; 95 % CI, 0.97–0.99),
hypertriglyceridemia (adjusted OR, 1.74; 95 % CI, 1.30–
2.33), BMI ≥25 kg/m2 (adjusted OR, 1.81; 95 % CI,
1.27–2.58), and abdominal obesity (adjusted OR, 1.75;
95 % CI, 1.30–2.35).
Discussion
To the best of our knowledge, the present study is the first
large-scale, population-based, cross-sectional survey to re-
port the relationships between elevated serum ALT levels
and cardiometabolic risk factors in a rural area of China.
Elevated serum ALT levels are most closely related to
liver fat accumulation and are commonly used as a
surrogate marker for nonalcoholic fatty liver disease in
epidemiological studies [22, 24]. Our study examined
significant associations of elevated serum ALT levels
with cardiometabolic risk factors in a rural Chinese
population. After adjustment for various confounders,
most of these associations remained significant. Sex and
age-adjusted current smoking were significantly related
to a lower likelihood of elevated serum ALT levels. Al-
though current smoking might constitute an important
risk factor with regard to liver function abnormalities
[25], this is not surprising because smoking lowers the
risk of type-2 diabetes, presumably by inhibiting auto-
immune processes [26]. Previous studies have found that
elevated ALT levels are associated with obesity and
metabolic syndrome, including a study performed in the
Japanese population [27] and a population-based cross-
sectional survey in Korean adolescents [28].
The central characteristics of metabolic syndrome are
hypertension, hyperglycemia, dyslipidemia, and abdom-
inal obesity. Consistent with the results of other epi-
demiological studies [27, 29], our study showed positive
associations between elevated serum ALT levels and
cardiometabolic risk factors, such as hypertension,
hypercholesterolemia, hypertriglyceridemia, low HDL-C
levels, and abdominal obesity. Diabetes is inversely pre-
dicted by lipoprotein(a) [30–32] and is strongly pre-
dicted by HtgW, which is also inversely predicted by
lipoprotein(a). ALT is assumed to be collinear with Lp(a)
and thereby acts as a mediator for cardiovascular risk
factors, including the HtgW phenotype. However, an as-
sociation between elevated ALT levels and diabetes mel-
litus was not found in our study.
In addition, we investigated the effect of sex on the asso-
ciations of elevated serum ALT levels with cardiometa-
bolic risk factors in a rural Chinese population. The
overall prevalence of elevated ALT levels in our study
Table 2 Adjusted ORs of Associated cardiometabolic risk
Factors for Elevated Serum ALT Level (Q40 U/L)
Variables OR 95 % CI P
Age, yrs 0.96 0.95–0.97 <0.001
Sex
female 1(referent) 一 一
male 2.98 2.44–3.64 <0.001
Race
Han 1(referent) 一 一
Others 0.78 0.55–1.10 0.158
Current smoking status 0.73 0.62–0.86 <0.001
Current drinking status 1.12 0.93–1.35 0.233
Hypertension 1.30 1.11–1.53 0.001
diabetes 1.22 0.98–1.52 0.073
High TC 1.57 1.26–1.96 <0.001
High TG 1.59 1.28–1.96 <0.001
Low HDL 1.27 1.03–1.55 0.022
High LDL 0.89 0.60–1.34 0.592
BMI≥ 25 kg/m2 1.51 1.18–1.94 0.001
Abdominal obesity 1.53 1.19–1.96 0.001
Hyperuricemia 1.78 1.47–2.16 <0.001
HtgW phenotype 1.37 1.07–1.76 0.012
Adjusted for age, sex, race, BMI, Current smoking status, Current drinking
status, Education, Physical activity, Family income, Hypertension, diabetes,
high TC, high TG, low HDL, high LDL, BMI ≥25 kg/m2, abdominal obesity,
Hyperuricemia and HtgW phenotype
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(7.4 % for men and women; 10.5 % and 4.8 %, respectively)
is similar to a previous population-based study that was
conducted in the general Chinese population [2], but is
much lower than another related study in China [33].
Multiple logistic regression analysis indicated that male
sex, a younger age, the presence of hypertension, hyper-
cholesterolemia, hypertriglyceridemia, low HDL-C levels,
BMI ≥25 kg/m2, abdominal obesity, hyperuricemia, and
the HtgW phenotype were independent predictors of an
elevated ALT level. Unsurprisingly, male sex and a
younger age represented significant risk factors that
were related to the likelihood of an elevated serum ALT
level. These results are consistent with the results of
other studies [9, 34]. Elevated serum ALT levels among
predominantly younger male adults remain unexplained
and deserve further attention [9]. Although our results
relating to the significant association between elevated
serum ALT levels and hyperuricemia appear to be simi-
lar to those of previous studies, the extent of elevation
seems to be dependent on the severity of the hepatic le-
sions [2, 35]. Based on the sex-related data, differences
in both sexes were present in the relationships between
elevated serum ALT levels and cardiometabolic risk
factors. For men, we found that elevated ALT levels
were closely associated with age, current smoking sta-
tus, hypertension, hypercholesterolemia, hypertriglyc-
eridemia, BMI ≥25 kg/m2, and hyperuricemia. However,
for women, elevated ALT levels were mainly associated
with age, hypertriglyceridemia, BMI ≥25 kg/m2, and ab-
dominal obesity.
Although current drinking status might be an import-
ant risk factor with regard to abnormalities of liver func-
tion in other population-based studies [2, 34], we did
not find any significance for this risk factor in our study.
In this sample of the rural Chinese population, we did
not observe an association between elevated serum ALT
levels and physical activity, even after adjustment for age
and sex. To the best of our knowledge, data on the asso-
ciation between physical activity and serum ALT levels
are limited. An inverse association between physical ac-
tivity and serum ALT levels among middle-aged British
women [11] and obese children [36] has been reported.
Several limitations in this study need to be acknowl-
edged. First, because of the cross-sectional design of our
study, we were unable to determine whether there was a
causal association between elevated ALT levels and cardio-
metabolic risk factors. Therefore, the obtained associations
in this study should be considered with caution. Second,
despite extensive adjustment in our study, unmeasured
confounders may explain part of the association between
elevated ALT levels and cardiometabolic risk factors.
There are known causes of elevated ALT levels that were
not tested in our study, such as alcohol abuse, chronic
viral hepatitis, and other illnesses. However, the strengths
of this study are its population-based design, large sample
size, and extensive information on confounders.
Table 3 Association between elevated ALT level and cardiometabolic risk factors according to the sex
Variables Male Female
OR 95 % CI P OR 95 % CI P
Age, yrs 0.95 0.94–0.96 <0.001 0.98 0.97–0.99 0.009
Race
Han 1(referent) 0.321 1(referent) 0.415
Others 0.78 0.51–1.19 0.274 0.73 0.40–1.33 0.309
Current smoking status 0.62 0.52–0.75 <0.001 1.06 0.76–1.48 0.733
Current drinking status 1.12 0.92–1.32 0.267 1.07 0.53–2.18 0.842
Hypertension 1.33 1.08–1.62 0.006 1.22 0.93–1.61 0.148
diabetes 1.21 0.91–1.61 0.192 1.23 089–1.76 0.195
High TC 1.63 1.23–2.17 0.001 1.38 0.96–1.99 0.084
High TG 1.62 1.25–2.09 <0.001 1.74 1.30–2.33 <0.001
Low HDL 1.23 0.96–1.58 0.096 1.33 0.93–1.89 0.116
High LDL 0.91 0.61–1.36 0.640 1.21 0.78–1.89 0.393
BMI≥ 25 kg/m2 1.52 1.07–2.18 0.021 1.81 1.27–2.58 0.001
Abdominal obesity 1.22 0.78–1.90 0.377 1.75 1.30–2.35 <0.001
Hyperuricemia 1.92 1.54–2.40 <0.001 1.34 0.90–1.99 0.145
HtgW phenotype 1.32 0.97–1.79 0.077 1.500 0.97–2.00 0.067
Adjusted for age, race, BMI, Current smoking status, Current drinking status,Education,Physical activity, Family income, Hypertension, diabetes, high TC, high TG,
low HDL, high LDL, BMI ≥25 kg/m2, abdominal obesity, Hyperuricemia and HtgW phenotype
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Conclusions
In conclusion, there is a significant association between
elevated ALT levels and cardiometabolic risk factors in
rural Northeast China in both sexes. Individuals with el-
evated ALT levels have a higher risk of cardiometabolic
abnormalities than those with normal ALT levels. There-
fore, elevated serum ALT levels are associated with a
worse cardiac risk profile. Further prospective studies
are required to verify these findings.
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